Abbott Laboratories (ABT) Other Working Capital Changes (2009 - 2026)
Abbott Laboratories' (ABT) quarterly Other Working Capital Changes came in at -$1.0 billion in Q2 2026, down 517.62% year-over-year from $244.0 million in Q2 2025, and down 342.62% quarter-over-quarter from $420.0 million in Q1 2026.
Analysis
Abbott Laboratories (ABT) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Abbott Laboratories has disclosed Other Working Capital Changes across 18 years of filings, most recently posting -$1.0 billion for Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.02 Bn |
| Jun 30, 2026 | -1.02 Bn |
| Mar 31, 2026 | 420.00 Mn |
| Mar 31, 2026 | 420.00 Mn |
| Sep 30, 2025 | -221.00 Mn |
| Sep 30, 2025 | -221.00 Mn |
| Jun 30, 2025 | 244.00 Mn |
| Jun 30, 2025 | 244.00 Mn |
| Mar 31, 2025 | 436.00 Mn |
| Mar 31, 2025 | 436.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | -140.00 Mn |
| Jun 30, 2024 | -140.00 Mn |
| Mar 31, 2024 | 748.00 Mn |
| Mar 31, 2024 | 748.00 Mn |
| Sep 30, 2023 | 179.00 Mn |
| Sep 30, 2023 | 179.00 Mn |
| Jun 30, 2023 | 660.00 Mn |
| Jun 30, 2023 | 660.00 Mn |